Epsilogen is a clinical-stage company pioneering radically new antibody therapeutics for oncology, focusing on the development of immunoglobulin IgE, IgA, and IgG-based therapeutics to treat various cancers
Epsilogen is a clinical-stage company pioneering radically new antibody therapeutics for oncology, focusing on the development of immunoglobulin IgE, IgA, and IgG-based therapeutics to treat various cancers.